CD8A and neoplasm: Some drugs, namely CPA, 5-Fu, and Dacarbazine, can sensitize tumor cells to CD8+ T cell-mediated apoptosis (148, 149), and thus may serve as ideal candidates for therapeutic combinations with various cancer immunotherapies.